Description

Drug development is an interconnected process — scientific, clinical, regulatory, and business decisions made at one stage shape what happens next.

Drug Development Pathways: A Four-Part Webinar Series provides an accessible, biotech-specific overview of the complete drug development pathway, from identifying promising drug candidates through regulatory approval and post-market activities.

Designed for professionals who are new to the industry or looking to broaden their understanding, each 60-minute webinar focuses on a key stage of development, highlighting the critical inputs required for that phase as well as the strategic outputs passed to the next.

Attend the complete series for a broader understanding of the drug development lifecycle, or select the individual webinars most relevant to your role and professional development goals.

Each live virtual webinar includes an interactive Q&A with the instructor.

Registration & Pricing

Build your understanding of the drug development lifecycle — one webinar at a time or across the full four-part series.

Participants may register for one individual webinar, a two-webinar bundle, or the complete four-part series.

Individual Webinar

• Member Rate: $79
• Non-Member Rate: $99

Two-Three Webinar Bundle

• Member Rate: $149 – $223
• Non-Member Rate: $186 – $280
• Use discount code BUNDLE at checkout to receive bundled rate

Full Four-Webinar Series

• Member Rate: $278
• Non-Member Rate: $348
• Use discount code SERIES at checkout to receive bundled rate

Want your organization to gain access to member rates? Email courses@massbioed.org for more information.

Webinar Schedule

Webinar 1: Foundations, Strategy & Candidate Selection

Tuesday, September 22, 2026 | 12:00–1:00 PM EDT

Explore the early drug development process, including identifying therapeutic targets, selecting viable drug candidates, and understanding the regulatory landscape that shapes early development.

Webinar 2: De-risking & Preclinical Development

Tuesday, September 29, 2026 | 12:00–1:00 PM EDT

Learn how organizations evaluate safety, establish manufacturing and regulatory strategies, and prepare successful Investigational New Drug (IND) applications before entering clinical trials.

Webinar 3: Clinical Trials & Patient Safety

Tuesday, October 6, 2026 | 12:00–1:00 PM EDT

Understand the purpose and design of Phases I–III clinical trials, patient safety monitoring, pharmacovigilance, and the role of external vendors in successfully conducting clinical research.

Webinar 4: Regulatory Approval & the Post-Market Lifecycle

Tuesday, October 13, 2026 | 12:00–1:00 PM EDT

Discover what happens after successful clinical trials, including regulatory submissions, commercialization planning, post-market surveillance, and lifecycle management.

Who Should Attend?

This webinar series is designed for professionals who want to better understand how their work fits into the broader drug development lifecycle, including:

• Individuals transitioning into the life sciences industry
• Professionals new to biotechnology or pharmaceuticals
• Scientists interested in understanding the broader development process
• Clinical research professionals
• Regulatory Affairs professionals beginning their careers
• Project managers supporting drug development teams
• Business development and commercialization professionals

Participants Will Learn To

By the end of the full series, participants will be able to:

• Explain the major stages of the drug development lifecycle
• Understand how scientific, regulatory, clinical, and commercial functions interact
• Recognize key milestones and decision points throughout development
• Describe the purpose of preclinical studies and clinical trial phases
• Understand the regulatory pathway from discovery through commercialization
• Recognize how their specific role fits into and impacts the broader, interconnected drug development lifecycle

Meet the Instructor

Tonya Pimentel
Principal Consultant, Pimentel Consulting LLC

Tonya Pimentel is a seasoned leader with 30 years of experience spanning the Cell & Gene Therapy, Vaccine, Biotech and Medical Device sectors. A Project Management Professional (PMP) and ASQ Certified Quality Auditor, Tonya has a proven track record of leading high-stakes initiatives, including facility startups, the remediation of quality systems under consent decrees, and the successful commercialization of complex biologics and gene therapies. As an instructor, Tonya brings a practical, “on-the-floor” perspective to Project Management, focusing on how strategic oversight and cross-functional leadership drive innovation and patient safety in the life sciences.

Questions?

For questions about the webinar series, registration options, or member pricing, contact courses@massbioed.org.